Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature
Background Both radiotherapy (RT) and cisplatin‐based chemoradiotherapy (CRT) in
patients with head and neck cancer may cause sensorineural hearing loss (SNHL). The …
patients with head and neck cancer may cause sensorineural hearing loss (SNHL). The …
Characteristics of radiation‐induced sensorineural hearing loss in head and neck cancer: A systematic review
M Mujica–Mota, S Waissbluth, SJ Daniel - Head & neck, 2013 - Wiley Online Library
Background Patients receiving radiotherapy (RT) for head and neck tumors are at risk of
developing sensorineural hearing loss. The objective of this study was to analyze the …
developing sensorineural hearing loss. The objective of this study was to analyze the …
c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells
T Sun, DD Li, LL Wang, LP Xia, JG Ma, Z Guan… - Journal of translational …, 2011 - Springer
Background Autophagy is a dynamic catabolic process characterized by the formation of
double membrane vacuoles termed autophagosomes. LC3, a homologue of yeast Atg8 …
double membrane vacuoles termed autophagosomes. LC3, a homologue of yeast Atg8 …
Mechanism and protection of radiotherapy induced sensorineural hearing loss for head and neck cancer
W Shi, X Hou, X Bao, W Hou, X Jiang… - BioMed Research …, 2021 - Wiley Online Library
Purpose. Radiotherapy‐induced sensorineural hearing loss (RISNHL) is a common adverse
effect in patients with head and neck cancer. Given that there are few studies on the …
effect in patients with head and neck cancer. Given that there are few studies on the …
Challenges of hearing rehabilitation after radiation and chemotherapy
ME Nader, PW Gidley - Journal of Neurological Surgery Part B …, 2019 - thieme-connect.com
Radiation and chemotherapy are frequently used in the treatment of head and neck
malignancies. Ototoxicity is a common adverse effect of these treatment modalities. This …
malignancies. Ototoxicity is a common adverse effect of these treatment modalities. This …
Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era—The Early and Late Effects of Radiation and Cisplatin
PL Yip, KCJ Mok, HS Ho, WYV Lee, ACL Wong… - Clinical Oncology, 2022 - Elsevier
Aims Hearing loss is a common debilitating complication in nasopharyngeal carcinoma
(NPC) survivors. The aim of the present study was to investigate the impact of inner …
(NPC) survivors. The aim of the present study was to investigate the impact of inner …
Impact of cochlear dose on hearing preservation following stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of vestibular …
LK Chung, N Ung, JP Sheppard… - … Surgery Part B: Skull …, 2018 - thieme-connect.com
Objective The objective of this study was to examine the effect of cochlear dose on hearing
preservation in stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy …
preservation in stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy …
Mechanisms of radiation-induced sensorineural hearing loss and radioprotection
MA Mujica-Mota, S Lehnert, S Devic, K Gasbarrino… - Hearing research, 2014 - Elsevier
Patients that receive radiotherapy are at risk of late sensorineural hearing loss when the
inner ear is included within the radiation field. Preclinical and human temporal bone studies …
inner ear is included within the radiation field. Preclinical and human temporal bone studies …
Long‐term hearing loss after chemoradiation in patients with head and neck cancer
EAR Theunissen, CL Zuur, SCJ Bosma… - The …, 2014 - Wiley Online Library
Objectives/Hypothesis The purpose of this study was to determine whether concomitant
chemoradiation (CCRT)‐induced hearing loss is progressive over time or not. Study Design …
chemoradiation (CCRT)‐induced hearing loss is progressive over time or not. Study Design …